Patents by Inventor Dennis Bourdette

Dennis Bourdette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sobetirome in the treatment of myelination diseases
    Patent number: 11510887
    Abstract: Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: November 29, 2022
    Assignees: Oregon Health & Science University, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Thomas S. Scanlan, Meredith Hartley, Andrew Placzek, Marco Righi, Dennis Bourdette, Gail Marracci, Priya Chaudhary
  • SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
    Publication number: 20200405669
    Abstract: Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 7, 2020
    Publication date: December 31, 2020
    Applicants: Oregon Health & Science University, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Thomas S. Scanlan, Meredith Hartley, Andrew Placzek, Marco Righi, Dennis Bourdette, Gail Marracci, Priya Chaudhary
  • SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
    Publication number: 20190175531
    Abstract: Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 13, 2019
    Applicants: Oregon Health & Science University, The United States Government as respresented by the Department of Veterans Affairs
    Inventors: Thomas S. Scanlan, Meredith Hartley, Andrew Placzek, Marco Righi, Dennis Bourdette, Gail Marracci, Priya Chaudhary
  • Sobetirome in the treatment of myelination diseases
    Patent number: 10226438
    Abstract: Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: March 12, 2019
    Assignees: Oregon Health & Science University, The United States of America as represented by the Department of Veterans Affairs
    Inventors: Thomas S. Scanlan, Meredith Hartley, Andrew Placzek, Marco Righi, Dennis Bourdette, Gail Marracci, Priya Chaudhary
  • SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
    Publication number: 20160081955
    Abstract: Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 5, 2014
    Publication date: March 24, 2016
    Applicants: Oregon Health & Science University, The United States Government as respresented by the Department of Veterans Affairs
    Inventors: Thomas S. Scanlan, Meredith Hartley, Andrew Placzek, Marco Righi, Dennis Bourdette, Gail Marracci, Priya Chaudhary
  • Cyclic undecapeptides and derivatives as multiple sclerosis therapies
    Patent number: 8394763
    Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of a cyclosporin compound.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: March 12, 2013
    Assignees: Oregon Health & Science University, The United States of America as represented by the Department of Veterans Affairs
    Inventors: Michael Forte, Dennis Bourdette, Gail Marracci
  • METHODS AND COMPOSITIONS FOR NERVE REGENERATION
    Publication number: 20100303934
    Abstract: A method of promoting nerve regeneration in a subject that includes administering to the subject a therapeutically effective amount of a composition that includes at least one therapeutically-active extract fraction of Centella asiatica. One example of making the extract fraction of Centella asiatica involves extracting Centella asiatica plant material resulting in an extract residue and successively fractionating the Centella asiatica extract residue with at least two eluants of increasing polarity.
    Type: Application
    Filed: June 3, 2010
    Publication date: December 2, 2010
    Inventors: Amala Soumyanath, Bruce G. Gold, Sandra Gold, Yong-Ping Zhong, Dennis Bourdette
  • CYCLIC UNDECAPEPTIDES AND DERIVATIVES AS MULTIPLE SCLEROSIS THERAPIES
    Publication number: 20100196317
    Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of a cyclosporin compound.
    Type: Application
    Filed: September 26, 2008
    Publication date: August 5, 2010
    Inventors: Michael Forte, Dennis Bourdette, Gail Marracci
  • Methods and compositions for nerve regeneration
    Publication number: 20070196522
    Abstract: A method of promoting nerve regeneration in a subject that includes administering to the subject a therapeutically effective amount of a composition that includes at least one therapeutically-active extract fraction of Centella asiatica. One example of making the extract fraction of Centella asiatica involves extracting Centella asiatica plant material resulting in an extract residue and successively fractionating the Centella asiatica extract residue with at least two eluants of increasing polarity.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 23, 2007
    Inventors: Amala Soumyanath, Bruce Gold, Sandra Gold, Yong-Ping Zhong, Dennis Bourdette